Lincoln Pharmaceuticals Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹166.32 crore, reflecting a quarter-on-quarter *(QoQ) increase of 1.81 per cent from ₹163.36 crore. This corresponds to a year-on-year *(YoY) growth of 13.49 per cent.
Operating Profit
Operating Profit stands at ₹23.59 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 7.20 per cent from ₹25.42 crore. This corresponds to a year-on-year *(YoY) decline of 0.30 per cent.
PBDT
PBDT stands at ₹38.44 crore, reflecting a quarter-on-quarter *(QoQ) increase of 18.53 per cent from ₹32.43 crore. This corresponds to a year-on-year *(YoY) growth of 20.46 per cent.
Profit Before Tax
Profit Before Tax stands at ₹34.72 crore, reflecting a quarter-on-quarter *(QoQ) increase of 20.51 per cent from ₹28.81 crore. This corresponds to a year-on-year *(YoY) growth of 21.02 per cent.
Net Profit
Net Profit stands at ₹28.60 crore, reflecting a quarter-on-quarter *(QoQ) increase of 43.14 per cent from ₹19.98 crore. This represents a 37.70 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Lincoln Pharmaceuticals Ltd Earnings
- YOY
- QOQ
Lincoln Pharmaceuticals Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Lincoln Pharmaceuticals Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Lincoln Pharmaceuticals Ltd Financial Reports
Lincoln Pharmaceuticals Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Lincoln Pharma. | 6.44% | 5.32% | 6.63% | 37.87% | 18.37% | 9.21% |
| Syncom Formul. | -2.65% | 1.16% | 24.20% | 18.71% | -16.71% | -20.91% |
| Hester Bios | 0.63% | 4.23% | 12.17% | 6.14% | -13.27% | -17.08% |
| Jagsonpal Pharma | -2.96% | -4.06% | 2.16% | 12.89% | -15.91% | -18.20% |
| Ind-Swift Labs. | 6.06% | -2.57% | 4.24% | 32.14% | 32.68% | 63.55% |
| Bajaj Healthcare | -2.22% | -4.06% | 12.05% | -6.23% | -25.23% | -45.02% |
| Fredun Pharma | 9.45% | 12.67% | 19.37% | 36.67% | 21.21% | 198.07% |
Company Info
Company Information
Chairman & Non Executive Dir. : Kishorbhai M Shah
ED / MD / Promoter : Mahendra G Patel
WTD & Executive Director : Hasmukhbhai I Patel
WTD & Executive Director : Ashish Rajanikant Patel
WTD & Executive Director : Munjal Mahendrabhai Patel
Non-Exec & Non-Independent Dir : Rajnikant G Patel
Independent Non Exe. Director : Saurin Jagdish Bhai Parikh
Independent Non Exe. Director : Nareshkumar Pirabhai Suthar
Independent Non Exe. Director : Seema Mehta
Company Sec. & Compli. Officer : Trusha Shah